Back to Search
DR. GREGORY H BEAN MD
MD
Obstetrics & Gynecology Physician
NPI: 1629069695IndividualAccepts Medicare
Specialties, Licenses & Credentials
Military Health Care Provider
Military Health Care Provider
Code: 171000000X
35075241(OR)
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
6901969-1205(UT)
Education
UNIFORMED SERVICES UHS FE HEBERT SCHOOL OF MED
Class of 1993
Research & Publications (20)
A22 disrupts the bacterial actin cytoskeleton by directly binding and inducing a low-affinity state in MreB.
PMID 19382805·Biochemistry·2009
8-other
CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.
PMID 19258476·Cancer Epidemiol Biomarkers Prev·2009
8-other
Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
PMID 19427617·Am J Ophthalmol·2009
4-observational
Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
PMID 18222194·Am J Ophthalmol·2008
4-observational
Results of a study comparing the stability, efficacy, and adverse effect profile of innovator formulation, latanoprost (Xalatan) ophthalmic solution 0.005%, with that of a new formulation of a latanoprost ophthalmic solution containing cyclodextrins.
PMID 18094225·J Clin Pharmacol·2008
4-observational
Polymerization properties of the Thermotoga maritima actin MreB: roles of temperature, nucleotides, and ions.
PMID 18095710·Biochemistry·2008
8-other
Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences.
PMID 19038626·Surv Ophthalmol·2008
6-review
ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention.
PMID 18708376·Cancer Epidemiol Biomarkers Prev·2008
8-other
Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk.
PMID 17220331·Cancer Epidemiol Biomarkers Prev·2007
8-other
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
PMID 18006786·Clin Cancer Res·2007
8-other
Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis in human mammary epithelial cells.
PMID 17016442·Oncogene·2007
8-other
Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology.
PMID 17372261·Cancer Epidemiol Biomarkers Prev·2007
8-other
Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention.
PMID 17507634·Cancer Epidemiol Biomarkers Prev·2007
8-other
Effects of irradiation on fungi and fumonisin B(1) in corn, and of microwave-popping on fumonisins in popcorn.
PMID 17613059·Food Addit Contam·2007
7-preclinical
Long-term raloxifene in a woman at high risk for breast cancer.
PMID 17035661·N Engl J Med·2006
5-case
Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.
PMID 15824145·Cancer Epidemiol Biomarkers Prev·2005
3-trial
CREB-binding protein regulates apoptosis and growth of HMECs grown in reconstituted ECM via laminin-5.
PMID 16219677·J Cell Sci·2005
8-other
Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
PMID 15173275·J Natl Cancer Inst·2004
8-other
Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells.
PMID 15467738·Oncogene·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1248 E 90 N STE 300
AMERICAN FORK, UT 84003 - Phone
- (801) 756-9635
Quick Facts
- NPI
- 1629069695
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile